ArticleRetina (Philadelphia, Pa.)2016

SYSTEMIC INTERLEUKIN 1β INHIBITION IN PROLIFERATIVE DIABETIC RETINOPATHY: A Prospective Open-Label Study Using Canakinumab.

Marc Stahel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.